343 related articles for article (PubMed ID: 7552926)
1. Safety of salmeterol in the maintenance treatment of asthma.
Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
[TBL] [Abstract][Full Text] [Related]
2. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
[TBL] [Abstract][Full Text] [Related]
3. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Malone R; LaForce C; Nimmagadda S; Schoaf L; House K; Ellsworth A; Dorinsky P
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol versus theophylline in the treatment of asthma.
Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
[TBL] [Abstract][Full Text] [Related]
7. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919
[TBL] [Abstract][Full Text] [Related]
8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
[TBL] [Abstract][Full Text] [Related]
11. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G; Williams DA; Weller P; Price JF
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol compared with current therapies in chronic asthma.
Adinoff AD; Schwartz HJ; Rickard KA; Yancey SW; Swearingen BE
J Fam Pract; 1998 Oct; 47(4):278-84. PubMed ID: 9789513
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
14. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Nathan RA; Pinnas JL; Schwartz HJ; Grossman J; Yancey SW; Emmett AH; Rickard KA
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478
[TBL] [Abstract][Full Text] [Related]
15. [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
Beeh KM; Wiewrodt R; Salem AE; Buhl R
Pneumologie; 2000 Jun; 54(6):225-31. PubMed ID: 10934892
[TBL] [Abstract][Full Text] [Related]
16. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
17. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring.
Kemp JP; Bierman CW; Cocchetto DM
Ann Allergy; 1993 Apr; 70(4):316-22. PubMed ID: 8466097
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML
Respir Med; 1999 Jul; 93(7):236-44. PubMed ID: 10464829
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
